Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012
Background and purpose: Strongyloidiasis is a nematode infection of humans with a worldwide distribution which is more prevalent in tropical and subtropical regions. Infected people are often clinically asymptomatic, however, in untreated immunosuppressed patients, it causes more than 80% mortality....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mazandaran University of Medical Sciences
2017-06-01
|
| Series: | Journal of Mazandaran University of Medical Sciences |
| Subjects: | |
| Online Access: | http://jmums.mazums.ac.ir/article-1-8651-en.html |
| _version_ | 1797943731954909184 |
|---|---|
| author | Moradali Fouladvand Afshin Barazesh Rahim Tahmasebi |
| author_facet | Moradali Fouladvand Afshin Barazesh Rahim Tahmasebi |
| author_sort | Moradali Fouladvand |
| collection | DOAJ |
| description | Background and purpose: Strongyloidiasis is a nematode infection of humans with a worldwide distribution which is more prevalent in tropical and subtropical regions. Infected people are often clinically asymptomatic, however, in untreated immunosuppressed patients, it causes more than 80% mortality. So, the accurate and timely diagnosis of infection can prevent patient's death. This study was conducted to determine the prevalence of strongyloidiasis in patients under chemotherapy and hemodialysis in Bushehr, Iran.
Materials and methods: We performed a cross-sectional study in 2011-2012 in which all chemotherapy and hemodialysis patients were evaluated by ELISA method to determine the presence of anti-Strongyloides stercoralis IgG antibody.
Results: A total of 214 individuals were studied from whom 4 (1.9%) patients under chemotherapy and 3 (1.4%) hemodialysis patients were positive for IgG antibody.
Conclusion: Strongyloidiasis is as a life-threatening risk factor in people under chemotherapy and hemodialysis, therefore, strongyloidiasis screening is suggested in these patients before administering immunosuppressive drugs, dialysis, and kidney transplant. |
| first_indexed | 2024-04-10T20:28:50Z |
| format | Article |
| id | doaj.art-acc68afa463448b58447a0e921dda1ec |
| institution | Directory Open Access Journal |
| issn | 1735-9260 1735-9279 |
| language | English |
| last_indexed | 2024-04-10T20:28:50Z |
| publishDate | 2017-06-01 |
| publisher | Mazandaran University of Medical Sciences |
| record_format | Article |
| series | Journal of Mazandaran University of Medical Sciences |
| spelling | doaj.art-acc68afa463448b58447a0e921dda1ec2023-01-25T07:52:57ZengMazandaran University of Medical SciencesJournal of Mazandaran University of Medical Sciences1735-92601735-92792017-06-0127149187191Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012Moradali Fouladvand0Afshin Barazesh1Rahim Tahmasebi2 Bushehr University of Medical Sciences Bushehr University of Medical Sciences Bushehr University of Medical Sciences Background and purpose: Strongyloidiasis is a nematode infection of humans with a worldwide distribution which is more prevalent in tropical and subtropical regions. Infected people are often clinically asymptomatic, however, in untreated immunosuppressed patients, it causes more than 80% mortality. So, the accurate and timely diagnosis of infection can prevent patient's death. This study was conducted to determine the prevalence of strongyloidiasis in patients under chemotherapy and hemodialysis in Bushehr, Iran. Materials and methods: We performed a cross-sectional study in 2011-2012 in which all chemotherapy and hemodialysis patients were evaluated by ELISA method to determine the presence of anti-Strongyloides stercoralis IgG antibody. Results: A total of 214 individuals were studied from whom 4 (1.9%) patients under chemotherapy and 3 (1.4%) hemodialysis patients were positive for IgG antibody. Conclusion: Strongyloidiasis is as a life-threatening risk factor in people under chemotherapy and hemodialysis, therefore, strongyloidiasis screening is suggested in these patients before administering immunosuppressive drugs, dialysis, and kidney transplant.http://jmums.mazums.ac.ir/article-1-8651-en.htmlstrongyloidiasischemotherapyhemodialysisbushehriran |
| spellingShingle | Moradali Fouladvand Afshin Barazesh Rahim Tahmasebi Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012 Journal of Mazandaran University of Medical Sciences strongyloidiasis chemotherapy hemodialysis bushehr iran |
| title | Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012 |
| title_full | Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012 |
| title_fullStr | Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012 |
| title_full_unstemmed | Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012 |
| title_short | Seroepidemiological Study of Strongyloidiasis in Patients Taking Immunosuppressive Drugs in Bushehr, Iran, 2012 |
| title_sort | seroepidemiological study of strongyloidiasis in patients taking immunosuppressive drugs in bushehr iran 2012 |
| topic | strongyloidiasis chemotherapy hemodialysis bushehr iran |
| url | http://jmums.mazums.ac.ir/article-1-8651-en.html |
| work_keys_str_mv | AT moradalifouladvand seroepidemiologicalstudyofstrongyloidiasisinpatientstakingimmunosuppressivedrugsinbushehriran2012 AT afshinbarazesh seroepidemiologicalstudyofstrongyloidiasisinpatientstakingimmunosuppressivedrugsinbushehriran2012 AT rahimtahmasebi seroepidemiologicalstudyofstrongyloidiasisinpatientstakingimmunosuppressivedrugsinbushehriran2012 |